167 related articles for article (PubMed ID: 16611677)
1. The search for a link between inflammation and hypertension--contribution from Bartter's/Gitelman's syndromes.
Pagnin E; Davis PA; Semplicini A; Calò LA
Nephrol Dial Transplant; 2006 Aug; 21(8):2340-2. PubMed ID: 16611677
[No Abstract] [Full Text] [Related]
2. Linking inflammation and hypertension in humans: studies in Bartter's/Gitelman's syndrome patients.
Caló LA; Davis PA; Pagnin E; Schiavo S; Semplicini A; Pessina AC
J Hum Hypertens; 2008 Mar; 22(3):223-5. PubMed ID: 18046435
[No Abstract] [Full Text] [Related]
3. Urinary albumin excretion, endothelial dysfunction and cardiovascular risk: study in Bartter's/Gitelman's syndromes and relevance for hypertension.
Calò LA; Davis PA; Palatini P; Semplicini A; Pessina AC
J Hum Hypertens; 2007 Nov; 21(11):904-6. PubMed ID: 17495949
[No Abstract] [Full Text] [Related]
4. Early markers of inflammation in a high angiotensin II state--results of studies in Bartter's/Gitelman's syndromes.
Davis PA; Mussap M; Pagnin E; Bertipaglia L; Savica V; Semplicini A; Calò LA
Nephrol Dial Transplant; 2006 Jun; 21(6):1697-701. PubMed ID: 16574683
[TBL] [Abstract][Full Text] [Related]
5. Increased level of p63RhoGEF and RhoA/Rho kinase activity in hypertensive patients.
Calò LA; Davis PA; Pagnin E; Dal Maso L; Maiolino G; Seccia TM; Pessina AC; Rossi GP
J Hypertens; 2014 Feb; 32(2):331-8. PubMed ID: 24356540
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathophysiology of Bartter's and Gitelman's syndromes.
Koulouridis E; Koulouridis I
World J Pediatr; 2015 May; 11(2):113-25. PubMed ID: 25754753
[TBL] [Abstract][Full Text] [Related]
7. Silencing regulator of G protein signaling-2 (RGS-2) increases angiotensin II signaling: insights into hypertension from findings in Bartter's/Gitelman's syndromes.
Calò LA; Pagnin E; Ceolotto G; Davis PA; Schiavo S; Papparella I; Semplicini A; Pessina AC
J Hypertens; 2008 May; 26(5):938-45. PubMed ID: 18398336
[TBL] [Abstract][Full Text] [Related]
8. Increased endothelial nitric oxide synthase mRNA level in Bartter's and Gitelman's syndrome. Relationship to vascular reactivity.
Calò L; Davis PA; Milani M; Cantaro S; Antonello A; Favaro S; D'Angelo A
Clin Nephrol; 1999 Jan; 51(1):12-7. PubMed ID: 9988141
[TBL] [Abstract][Full Text] [Related]
9. The PGC1alpha-PPARdelta-HO-1 system: supporting evidence from studies in Bartter's/Gitelman's syndromes.
Calò LA; Davis PA
Cardiovasc Res; 2010 Jun; 86(3):535. PubMed ID: 20228397
[No Abstract] [Full Text] [Related]
10. Mechanistic approach to the pathophysiology of target organ damage in hypertension from studies in a human model with characteristics opposite to hypertension: Bartter's and Gitelman's syndromes.
Calò LA; Maiolino G
J Endocrinol Invest; 2015 Jul; 38(7):711-6. PubMed ID: 25740064
[TBL] [Abstract][Full Text] [Related]
11. ACE2/Angiotensin 1-7 protective anti-inflammatory and antioxidant role in hyperoxic lung injury: support from studies in Bartter's and Gitelman's syndromes.
Calò LA; Rigato M; Bertoldi G
QJM; 2020 Jun; 113(6):440-441. PubMed ID: 31851364
[No Abstract] [Full Text] [Related]
12. Analyses of subjects with hypokalemic metabolic alkolosis, Gitelman's and Bartter's syndrome.
Onem Y; Kucukardali Y; Sahan B; Atasoyu EM; Ipcioğlu O; Terekeci H; Solmazgul E; Top C; Oktenli C
Ren Fail; 2008; 30(7):691-4. PubMed ID: 18704817
[TBL] [Abstract][Full Text] [Related]
13. Absence of vascular remodelling in a high angiotensin-II state (Bartter's and Gitelman's syndromes): implications for angiotensin II signalling pathways.
Calò LA; Puato M; Schiavo S; Zanardo M; Tirrito C; Pagnin E; Balbi G; Davis PA; Palatini P; Pauletto P
Nephrol Dial Transplant; 2008 Sep; 23(9):2804-9. PubMed ID: 18344243
[TBL] [Abstract][Full Text] [Related]
14. ACE2 and angiotensin 1-7 are increased in a human model of cardiovascular hyporeactivity: pathophysiological implications.
Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC
J Nephrol; 2010; 23(4):472-7. PubMed ID: 20349406
[TBL] [Abstract][Full Text] [Related]
15. Understanding the mechanisms of angiotensin II signaling involved in hypertension and its long-term sequelae: insights from Bartter's and Gitelman's syndromes, human models of endogenous angiotensin II signaling antagonism.
Calò LA; Davis PA; Rossi GP
J Hypertens; 2014 Nov; 32(11):2109-19; discussion 2119. PubMed ID: 25202962
[TBL] [Abstract][Full Text] [Related]
16. Hypokalemic nephropathy in an adult patient with partial empty sella: a classic Bartter's syndrome, a Gitelman's syndrome or both?
Addolorato G; Ancarani F; Leggio L; Abenavoli L; de Lorenzi G; Montalto M; Staffolani E; Zannoni GF; Costanzi S; Gasbarrini G
Panminerva Med; 2006 Jun; 48(2):137-42. PubMed ID: 16953151
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II and Cardiovascular-Renal Remodelling in Hypertension: Insights from a Human Model Opposite to Hypertension.
Ravarotto V; Pagnin E; Fragasso A; Maiolino G; Calò LA
High Blood Press Cardiovasc Prev; 2015 Sep; 22(3):215-23. PubMed ID: 25759028
[TBL] [Abstract][Full Text] [Related]
18. Chondrocalcinosis is a feature of Gitelman's variant of Bartter's syndrome. A new look at the hypomagnesemia associated with calcium pyrophosphate dihydrate crystal deposition disease.
Punzi L; Calò L; Schiavon F; Pianon M; Rosada M; Todesco S
Rev Rhum Engl Ed; 1998 Oct; 65(10):571-4. PubMed ID: 9809361
[TBL] [Abstract][Full Text] [Related]
19. Vascular tone control in humans: insights from studies in Bartter's/Gitelman's syndromes.
Calò LA
Kidney Int; 2006 Mar; 69(6):963-6. PubMed ID: 16528244
[TBL] [Abstract][Full Text] [Related]
20. High angiotensin II state without cardiac remodeling (Bartter's and Gitelman's syndromes): are angiotensin II type 2 receptors involved?
Calò LA; Montisci R; Scognamiglio R; Davis PA; Pagnin E; Schiavo S; Mormino P; Semplicini A; Palatini P; D'Angelo A; Pessina AC
J Endocrinol Invest; 2009 Nov; 32(10):832-6. PubMed ID: 19605975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
